BMI & MASLD: Timing Matters for Prognosis

by Grace Chen

BOSTON, February 10, 2026 — The timing of a body mass index (BMI) measurement can significantly impact the prognosis for individuals with metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), according to recent research.

Timing Matters in Assessing Liver Disease

New findings suggest BMI readings taken during specific times of the year can better predict the severity of MASH.

  • BMI measurements taken in the fall may be more indicative of MASH severity than those taken in the spring.
  • Seasonal variations in diet and physical activity could explain the differing BMI-MASH correlations.
  • The study highlights the importance of considering measurement timing when evaluating patients with metabolic dysfunction-associated liver disease.

How does the time of year affect the relationship between BMI and MASH? Researchers found that BMI measurements taken in the fall showed a stronger association with the presence and severity of MASH than those taken in the spring.

Seasonal Variations and Metabolic Health

The study, involving 2,471 individuals with suspected MASH, revealed that a higher BMI in the fall correlated more strongly with histological features of MASH, including inflammation and fibrosis. This suggests that seasonal changes in lifestyle factors, such as diet and physical activity, may play a role in the progression of the disease.

“Our findings suggest that BMI measurements taken at different times of the year may provide different levels of prognostic information in patients with MASH,” explained Dr. Dominic Moore, lead author of the study.

Researchers analyzed data from patients who underwent liver biopsies between January 2018 and December 2022. BMI was calculated based on height and weight measurements taken at the time of the biopsy. The study population included individuals from multiple centers across the United States.

The Link Between Fall BMI and Liver Fibrosis

Specifically, the correlation between fall BMI and liver fibrosis was more pronounced than that observed with spring BMI measurements. This finding raises the possibility that fall BMI could serve as a more reliable indicator of disease progression and treatment response.

Q: Can the timing of a BMI measurement influence a MASH diagnosis?

A: Yes, research indicates that BMI measurements taken in the fall may be more strongly correlated with the severity of MASH, including inflammation and fibrosis, than those taken in the spring, potentially impacting diagnostic assessments.

The researchers acknowledge that further studies are needed to confirm these findings and to elucidate the underlying mechanisms driving the seasonal variations in BMI-MASH associations. However, the current data suggest that clinicians should consider the timing of BMI measurements when evaluating patients with suspected MASH.

Implications for Clinical Practice

The study’s findings have important implications for clinical practice. Clinicians may want to consider obtaining BMI measurements during the fall months to obtain a more accurate assessment of MASH risk and severity. Additionally, lifestyle interventions aimed at improving metabolic health may be particularly effective when implemented during the fall and winter months.

The study did not investigate the specific dietary or physical activity patterns that contribute to the observed seasonal variations. Future research should focus on identifying these factors to develop more targeted interventions.

Do you have thoughts on how seasonal factors impact metabolic health? Share your comments below.


You may also like

Leave a Comment